Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Grigoleit

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|May 14, 1983
Effect on salivary enzymes of alpha-amylase inhibitor HOE 467W Rupp, H G Grigoleit, H Grötsch
European Journal of Clinical Pharmacology|January 1, 1986
The absorption of piretanide from the gastro-intestinal tract is site-dependentD Brockmeier, H G Grigoleit, H Leonhardt
Die Medizinische Welt|May 26, 1978
[Effects of smoking and oral contraceptives on plasma and whole blood viscosity. Rheologic studies on normal subjects]H Leonhardt, H G Grigoleit, I Reinhardt
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1986
A new aspect of serum protein binding of tolbutamideG Ayanoğlu, M Uihlein, H G Grigoleit
Lancet (London, England)|February 12, 1983
Starch blockersK E Draeger, L Vértesy, H G Grigoleit
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
Red blood cell aging as a model to influence pharmacologically the red cell filterabilityH G Grigoleit, H Leonhardt, R Schröer, et al.
European Journal of Clinical Pharmacology|April 4, 1975
Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in manG Offermann, K Schaefer, H G Grigoleit, et al.
Medizinische Klinik|February 11, 1977
[Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)]K Schaefer, D von Herrath, A Hensel, et al.
Deutsche Medizinische Wochenschrift (1946)|July 1, 1973
[Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency]D von Herrath, D Kraft, H G Grigoleit, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1986
Kinetics of piretanide absorption from the gastrointestinal tractD Brockmeier, H G Grigoleit, H Heptner, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|May 14, 1983
Effect on salivary enzymes of alpha-amylase inhibitor HOE 467W Rupp, H G Grigoleit, H Grötsch
European Journal of Clinical Pharmacology|January 1, 1986
The absorption of piretanide from the gastro-intestinal tract is site-dependentD Brockmeier, H G Grigoleit, H Leonhardt
Die Medizinische Welt|May 26, 1978
[Effects of smoking and oral contraceptives on plasma and whole blood viscosity. Rheologic studies on normal subjects]H Leonhardt, H G Grigoleit, I Reinhardt
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1986
A new aspect of serum protein binding of tolbutamideG Ayanoğlu, M Uihlein, H G Grigoleit
Lancet (London, England)|February 12, 1983
Starch blockersK E Draeger, L Vértesy, H G Grigoleit
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
Red blood cell aging as a model to influence pharmacologically the red cell filterabilityH G Grigoleit, H Leonhardt, R Schröer, et al.
European Journal of Clinical Pharmacology|April 4, 1975
Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in manG Offermann, K Schaefer, H G Grigoleit, et al.
Medizinische Klinik|February 11, 1977
[Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)]K Schaefer, D von Herrath, A Hensel, et al.
Deutsche Medizinische Wochenschrift (1946)|July 1, 1973
[Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency]D von Herrath, D Kraft, H G Grigoleit, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1986
Kinetics of piretanide absorption from the gastrointestinal tractD Brockmeier, H G Grigoleit, H Heptner, et al.
Pageof 5